Competent Cells Market Size, Share, Trends & Global Forecast 2022

-
The global competent cells market is projected to reach USD 2.22 billion by 2022 from USD 1.37 billion in 2017, at a CAGR of 10.2%.
Globally, the competent cells market is witnessing a high growth due to factors such as advancements in molecular cloning research due to the emergence of new technologies and the growing commercial demand for molecular cloned products and recombinant proteins.
Key players operating in this market are focusing on acquisitions to strengthen their position. For instance, in November 2015, Merck KGaA (Germany) completed the acquisition of Sigma-Aldrich Co. LLC. (Germany) for USD 17 billion. Sigma-Aldrich Co., LLC is one of the key manufacturers of competent cells. In addition, in March 2017, Thermo Fisher Scientific, Inc. (U.S.) collaborated with Cell and Gene Therapy Catapult (CGT Catapult) (U.K.). Similarly, in February 2014, Thermo Fisher Scientific, Inc. acquired Life Technologies, Inc. (U.S.) to enhance its presence in the competent cells market.
The global competent cell is segmented on the basis of type, which includes chemically competent cells and electrocompetent cells. The chemically competent cells segment is expected to account for the largest share of the market in 2017. This large share can be attributed to the rising intensity of research (due to technological advancement) and availability of government support, along with the growing market demand for molecular cloned products. However, the electrocompetent cells segment is expected to grow at the highest CAGR during the forecast period.
On the basis of application, the market is broadly segmented into cloning, protein expression, and other applications. Cloning is expected to command the largest share of this market in 2017. The market is driven by factors such as increasing research on cloning driven by government support and funding. This application segment is further categorized into subcloning & routine cloning, phage display library construction, toxic/unstable DNA cloning, and high-throughput cloning. Similarly, other applications of competent cells include mutagenesis, single-stranded DNA production, lentiviral vector production, and large plasmid transformation.
Based on end user, the competent cells market has been segmented into academic research institutes, contract research organizations (CROs), and pharmaceutical & biotechnology companies. The pharmaceutical & biotechnology companies segment is expected to witness the highest growth during 2017–2022. This is primarily due to the rising investments in research for developing genomics and proteomics-based products.
By region, the competent cells market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). The North America region is expected to grow at the fastest CAGR during the forecast period. This can be attributed to the increasing intensity of research due to technological advancement and increasing commercial needs for genomic and protein expressed products, in North American countries.
Emerging market such as Brazil, Russia, India, and China are expected to present significant opportunities for the growth of the competent cells market. Also, emerging applications of competent cells are key opportunities for this market to grow. Other applications of competent cells, such as lentiviral vector production, mutagenesis, and large plasmid transformation, have emerged in the last few years. Considering the growth prospects of these emerging application segments, some companies are offering technologically advanced products for lentiviral vector production, mutagenesis, and large plasmid transformation. For instance, Lucigen (U.S.) launched Endura electrocompetent cells, which are highly recommended by researchers for lentiviral libraries of CRISPR clones, particularly the GeCKO v2.0 plasmid libraries (REF). Similarly, OriGene Technologies, Inc. (U.S.) offers CRISPR/Cas9-based kits.
Know more:
https://www.marketsandmarkets.com/Market-Reports/competent-cells-market-265815900.html
https://www.marketsandmarkets.com/PressReleases/competent-cells.asp

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
newsletter@marketsandmarkets.com  

Comments

Post a Comment

Popular posts from this blog

Future of Remote Patient Monitoring Industry: Impact of Remote Patient Monitoring on Healthcare

-
Remote patient monitoring is a type of telemedicine technology that enables healthcare providers to monitor their patients’ health remotely. This technology utilizes remote devices that are placed in the patient’s home or worn by the patient to collect medical data such as vital signs and other medical information.  This medical data is then transmitted to the doctor or healthcare provider to help them make better decisions regarding the patient’s care. RPM can be used to monitor a variety of conditions including chronic diseases, mental health issues, and post-operative care. It can also be used to support elderly individuals and those with disabilities. RPM has the potential to improve patient outcomes and reduce healthcare costs by enabling healthcare providers to monitor their patients’ health more effectively. Benefits of Remote Patient Monitoring 1. Increased Patient Engagement: Remote patient monitoring systems provide patients with a convenient way to stay engaged in thei...
Read more

Strategies Adopted by the Major Players in this Digital PCR Market

-
 According to research report the  Digital PCR Market  is expected to grow from USD 3.47 billion in 2017 to USD 5.31 billion by 2022, at a CAGR of 8.9% during the forecast period. Product Launches: Key Strategy Adopted by the Major Players in this Market New product launches and approvals are the key growth strategies adopted by major players to strengthen their position in the global Digital PCR Market. Moreover, strategies such as partnerships, collaborations, and agreements; as well as mergers and acquisitions were also adopted by several market players to strengthen their market position, expand their R&D capabilities, and geographic presence in the global Digital PCR Market. The key players in the Digital PCR Market include Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Netherlands), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Fluid...
Read more

Sinus Dilation Devices Market Size And Share Report, 2027

-
The sinus dilation devices market is on track for significant growth in the coming years, projected to reach USD 3.8 billion by 2027, up from USD 2.8 billion in 2022. This represents a compound annual growth rate (CAGR) of 6.6% during the forecast period. The market's expansion is largely driven by the increasing availability of reimbursements and rising cases of chronic sinusitis. However, the market faces challenges due to the availability of non-surgical treatments for chronic sinusitis and a shortage of skilled ENT surgeons. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810 Key Market Drivers Increasing Availability of Reimbursements: The growing availability of reimbursements for sinus dilation procedures is making them more accessible to patients, thereby driving demand for sinus dilation devices. Rising Incidence of Chronic Sinusitis: The prevalence of chronic sinusitis is on the rise globally, leading to an increase in d...
Read more